AGP Executive Report
Last update: 6 hours agoBiotech: Taiwan’s OBI Pharma signed a deal with Novartis to develop antibody-drug conjugates, with potential payments exceeding US$2 billion, including a US$30 million upfront payment. Public Health: A woman was hospitalized after a suspected Taiwan habu bite in Taipei; officials urged residents to call emergency services if someone is bitten. Taiwan also issued a Level 2 measles travel alert for the entire United States. Child Nutrition: Taiwan, PCAA and JICA launched a recipe book aimed at improving preschool nutrition. Digital Health: Taiwan’s APEC representative brought the island’s AI health agenda to the forum, highlighting its push to shape regional health technology discussions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.